Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Plant Science,General Medicine
Link
http://link.springer.com/article/10.1007/s00709-017-1129-5/fulltext.html
Reference111 articles.
1. Abbas O, Richards JE, Mahalingam M (2010) Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma. Mod Pathol, Inc 23:1535–1543. doi: 10.1038/modpathol.2010.142
2. Abbott CA, Yu D, McCaughan GW, Gorrell MD (2000a) Post-proline-cleaving peptidases having DP IV like enzyme activity. Adv Exp Med Biol 477:103–109. doi: 10.1007/0-306-46826-3_10
3. Abbott CA, Yu DM, Woollatt E, Sutherland GR, McCaughan GW, Gorrell MD (2000b) Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem 267:6140–6150
4. Acharya PS, Zukas A, Chandan V, Katzenstein AL, Pure E (2006) Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol 37:352–360
5. Aertgeerts K et al (2005) Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem 280:19441–19444. doi: 10.1074/jbc.C500092200
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fibroblast Activation Protein Is Expressed by Altered Osteoprogenitors and Associated to Disease Burden in Fibrous Dysplasia;Cells;2024-08-27
2. In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions;EJNMMI Radiopharmacy and Chemistry;2024-07-29
3. FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature;Cancers;2024-02-19
4. Pharmacoproteomics and Rheumatoid Arthritis Management;Pharmacoproteomics;2024
5. Beyond FDG: FAPI Role in Cancer Imaging;Interdisciplinary Cancer Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3